Article
Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.
Blood - 15 Nov 2012
Schuh Anna, Becq Jennifer, Humphray Sean, Alexa Adrian, Burns Adam, Clifford Ruth, Feller Stephan M, Grocock Russell, Henderson Shirley, Khrebtukova Irina, Kingsbury Zoya, Luo Shujun, McBride David, Murray Lisa, Menju Toshi, Timbs Adele, Ross Mark, Taylor Jenny, Bentley David
Abstract excerpt
Chronic lymphocytic leukemia is characterized by relapse after treatment and chemotherapy resistance. Similarly, in other malignancies leukemia cells accumulate mutations during growth, forming heterogeneous cell populations that are subject to Darwinian selection and may respond differentially to treatment. There is therefore a clinical need to monitor changes in the subclonal composition of cancers during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
